Specialty market
China Orthopedic Surgery Market Outlook 2026
China's orthopedic surgery market reached USD 19.8 billion in 2025 with a 10.4% CAGR through 2030, propelled by population aging, robotic joint replacement adoption and rapid growth in inbound sports-medicine and arthroplasty tourism.
Market size (2025)
USD 19.8 billion
CAGR
10.4%
Forecast (2030)
USD 32.5 billion
Geography
Mainland China orthopedic surgery — knee, hip, spine, trauma, sports medicine
International-patient cost band
$9,000–$14,000 USD
Market size, 2021–2030
Mainland China orthopedic surgery — knee, hip, spine, trauma, sports medicine.
| Year | Market size (USD) | Status |
|---|---|---|
| 2021 | USD 11.8 billion | Historical |
| 2022 | USD 13.5 billion | Historical |
| 2023 | USD 15.4 billion | Historical |
| 2024 | USD 17.5 billion | Historical |
| 2025 | USD 19.8 billion | Latest actual |
| 2026 | USD 21.8 billion | Forecast |
| 2030 | USD 32.5 billion | Forecast |
Demand drivers
- Population aged 60+: 297 million in 2024, projected 400 million by 2035 — driving osteoarthritis demand.
- Volume-based procurement (VBP) on joint implants cut prices ~80% for domestic patients, dramatically expanding case volume.
- Robotic arthroplasty (MAKO, ROSA, domestic systems Yuanhua, Tianzhihang) rolled out across tier-1 cities.
- Inbound sports medicine demand from US/UK/AU patients with NHS-comparable outcomes at 40–60% of home private prices.
Supply-side landscape
- Top centres: Shanghai Sixth People's Hospital, PKU Third Hospital, PUMCH Orthopedics, Beijing Jishuitan (the national bone hospital), West China Hospital, Sun Yat-sen Memorial.
- International patient cost: knee replacement USD 9,500–14,000, hip replacement USD 9,000–13,500 vs US private USD 35,000–60,000.
- Sports medicine: ACL, rotator cuff, cartilage repair offered at HSS-tier outcomes by Shanghai Sixth, PKU Third, HKU-Shenzhen.
Risks & headwinds
- DRG bundling pressure on implant choice — international patients should specify implant brand in writing.
- Domestic implant share (Aikang, Weigao, Trauson) growing; international patients can specify Zimmer/Stryker/DePuy with no quality difference at premium tiers but cost difference.
- Long fly-home prophylaxis window (12–14 days) is a logistics consideration vs Thailand/Turkey shorter pathways.
Notable providers
Class A
Shanghai Sixth People's Hospital
Microsurgery and sports medicine — birthplace of modern limb replantation.
Class APKU Third Hospital
Highest-volume joint replacement and complex spine in Beijing.
Class ABeijing Jishuitan Hospital
China's national orthopedic / trauma hospital.
Class AWest China Hospital
Tier-2 city pricing for routine joint replacement with Class A volumes.
Frequently asked
- How big is the China orthopedic surgery market in 2026?
- USD 19.8 billion in 2025, forecast to USD 32.5 billion by 2030 (10.4% CAGR). Joint replacement, spine surgery and sports medicine are the fastest-growing sub-segments.
- How much does knee replacement cost in China for international patients?
- USD 9,500–14,000 all-in at a Class A international department with international-brand implants (Zimmer Persona, Stryker Triathlon, DePuy Attune), versus USD 35,000–60,000 in US private settings — a 70–80% saving before travel costs.
- Which Chinese hospitals lead in orthopedic surgery?
- Shanghai Sixth People's, PKU Third, PUMCH, Beijing Jishuitan (the national bone hospital), Sun Yat-sen Memorial and West China Hospital are the top-tier centres for international patients.
Sources
- Chinese Orthopaedic Association annual surgical volume report 2024
- National Healthcare Security Administration VBP implant pricing 2023–2025
- Frost & Sullivan China Orthopedic Devices Market Outlook 2026
- Partner-network 2026 international-patient orthopedic quote data
Last reviewed: 2026-05-12.
Going beyond the report
For a written quote from two Class A international departments — covering procedure, hospital match, recovery and visa — start the quote wizard.